Brief: Zevra Therapeutics Q2 revenue USD 8.47 million
14/08/2023 14:34
Aug 14 (Reuters) - Zevra Therapeutics Q2 revenue USD 8.47 million. * Q2 operating expenses USD 15.115 million * Q2 pretax profit USD -5.158 million * Q2 net income USD -5.084 million * Q2 income from operations USD -6.645 million
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor